Sterility Testing of Immonobiological Medicinal Products in Russia. Historical Background and Current Requirements
Sterility is one of the key parameters of biological safety of immunobiological medicinal products. The article traces the history of the development of sterility test methods for immunobiological medicinal products from as far back as 1961 and up to the current requirements laid down in the Stat...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-03-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/116 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849242956605685760 |
|---|---|
| author | S. M. Sukhanova Z. E. Berdnikova N. E. Zakharov V. A. Merkulov |
| author_facet | S. M. Sukhanova Z. E. Berdnikova N. E. Zakharov V. A. Merkulov |
| author_sort | S. M. Sukhanova |
| collection | DOAJ |
| description | Sterility is one of the key parameters of biological safety of immunobiological medicinal products. The article traces the history of the development of sterility test methods for immunobiological medicinal products from as far back as 1961 and up to the current requirements laid down in the State Pharmacopoeia of the Russian Federation, 13th edition. The article provides a detailed analysis of major approaches to the improvement of medicines quality evaluation based on this parameter, namely to the choice of: optimal growth media and methods of their evaluation, sensitive test strains, incubation conditions, the number of test samples (i.e., sample size) required for reliable demonstration of batch sterility; as well as approaches to the development of a test design that would accommodate specific aspects of production and use of immunobiological products. The article dwells upon the longstanding use of the sterility testing scheme developed in the national agency for control of immunobiological products — L.A. Tarasevich State Institute for Standardization and Control of Medicinal Immunobiological Products. The article analyses the current status of harmonisation of requirements for sterility testing of immunobiological products and other groups of medicines with those of the leading world pharmacopoeias, and prospects of using these requirements in the Eurasian Economic Union. |
| format | Article |
| id | doaj-art-ca0b779827644c52937c8f43a5c280ed |
| institution | Kabale University |
| issn | 2221-996X 2619-1156 |
| language | Russian |
| publishDate | 2018-03-01 |
| publisher | Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» |
| record_format | Article |
| series | Биопрепараты: Профилактика, диагностика, лечение |
| spelling | doaj-art-ca0b779827644c52937c8f43a5c280ed2025-08-20T03:59:39ZrusMinistry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Биопрепараты: Профилактика, диагностика, лечение2221-996X2619-11562018-03-0118151510.30895/2221-996X-2018-18-1-5-15115Sterility Testing of Immonobiological Medicinal Products in Russia. Historical Background and Current RequirementsS. M. Sukhanova0Z. E. Berdnikova1N. E. Zakharov2V. A. Merkulov3Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationSterility is one of the key parameters of biological safety of immunobiological medicinal products. The article traces the history of the development of sterility test methods for immunobiological medicinal products from as far back as 1961 and up to the current requirements laid down in the State Pharmacopoeia of the Russian Federation, 13th edition. The article provides a detailed analysis of major approaches to the improvement of medicines quality evaluation based on this parameter, namely to the choice of: optimal growth media and methods of their evaluation, sensitive test strains, incubation conditions, the number of test samples (i.e., sample size) required for reliable demonstration of batch sterility; as well as approaches to the development of a test design that would accommodate specific aspects of production and use of immunobiological products. The article dwells upon the longstanding use of the sterility testing scheme developed in the national agency for control of immunobiological products — L.A. Tarasevich State Institute for Standardization and Control of Medicinal Immunobiological Products. The article analyses the current status of harmonisation of requirements for sterility testing of immunobiological products and other groups of medicines with those of the leading world pharmacopoeias, and prospects of using these requirements in the Eurasian Economic Union.https://www.biopreparations.ru/jour/article/view/116national control authoritypharmacopoeiasterilitymedicinal immunobiological productsmicrobiological safetymembrane filtrationdirect inoculationcontaminationmerthiolatequality evaluation |
| spellingShingle | S. M. Sukhanova Z. E. Berdnikova N. E. Zakharov V. A. Merkulov Sterility Testing of Immonobiological Medicinal Products in Russia. Historical Background and Current Requirements Биопрепараты: Профилактика, диагностика, лечение national control authority pharmacopoeia sterility medicinal immunobiological products microbiological safety membrane filtration direct inoculation contamination merthiolate quality evaluation |
| title | Sterility Testing of Immonobiological Medicinal Products in Russia. Historical Background and Current Requirements |
| title_full | Sterility Testing of Immonobiological Medicinal Products in Russia. Historical Background and Current Requirements |
| title_fullStr | Sterility Testing of Immonobiological Medicinal Products in Russia. Historical Background and Current Requirements |
| title_full_unstemmed | Sterility Testing of Immonobiological Medicinal Products in Russia. Historical Background and Current Requirements |
| title_short | Sterility Testing of Immonobiological Medicinal Products in Russia. Historical Background and Current Requirements |
| title_sort | sterility testing of immonobiological medicinal products in russia historical background and current requirements |
| topic | national control authority pharmacopoeia sterility medicinal immunobiological products microbiological safety membrane filtration direct inoculation contamination merthiolate quality evaluation |
| url | https://www.biopreparations.ru/jour/article/view/116 |
| work_keys_str_mv | AT smsukhanova sterilitytestingofimmonobiologicalmedicinalproductsinrussiahistoricalbackgroundandcurrentrequirements AT zeberdnikova sterilitytestingofimmonobiologicalmedicinalproductsinrussiahistoricalbackgroundandcurrentrequirements AT nezakharov sterilitytestingofimmonobiologicalmedicinalproductsinrussiahistoricalbackgroundandcurrentrequirements AT vamerkulov sterilitytestingofimmonobiologicalmedicinalproductsinrussiahistoricalbackgroundandcurrentrequirements |